NEULANDLAB2022-10-012022-12-31 NEULANDLAB2022-10-012022-12-31 NEULANDLAB2022-10-012022-12-31in-bse-fin:OneOperatingExpenses01Member NEULANDLAB2022-10-012022-12-31in-bse-fin:OneOperatingExpenses02Member NEULANDLAB2022-10-012022-12-31in-bse-fin:FourOperatingExpenses01Member NEULANDLAB2022-10-012022-12-31in-bse-fin:FourOperatingExpenses02Member NEULANDLAB2022-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524558 NEULANDLAB NOTLISTED Neuland Laboratories Limited Equity 2022-04-01 2023-03-31 2023-02-13 2023-01-20 INR Lakhs Third quarter 15:50:00 17:30:00 2023-02-13 2023-02-13 Not applicable Single segment Manufacturing of Active Pharmaceuticals 2022-10-01 2022-12-31 Unaudited Standalone 2692500000.00 9331000.00 2701831000.00 1320018000.00 0.00 -264472000.00 498889000.00 27447000.00 133362000.00 598629000.00 2313873000.00 387958000.00 0.00 387958000.00 66215000.00 17380000.00 83595000.00 0.00 304363000.00 0.00 0.00 0.00 0.00 304363000.00 -16778000.00 287585000.00 0.00 0.00 129005000.00 10 23.72 23.72 0.00 0.00 23.72 23.72 1. The financial results for the quarter and nine months ended 31 December 2022 have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 13th February 2023. 2. The financial results have been prepared in accordance with the Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3. The operations of the Company are predominantly related to the manufacture and sale of active pharmaceutical ingredients and allied services. As such there is only one primary reportable segment as per Ind AS 108 Operating Segments . 4. The EPS for quarters has not been annualised. 5. The previous period figures have been regrouped/rearranged wherever necessary to make it comparable with the current period. Single segment 2022-04-01 2022-12-31 Unaudited Standalone 7841254000.00 16840000.00 7858094000.00 3498178000.00 0.00 -448270000.00 1470546000.00 87781000.00 393063000.00 1804893000.00 6806191000.00 1051903000.00 0.00 1051903000.00 250538000.00 15276000.00 265814000.00 0.00 786089000.00 0.00 0.00 0.00 0.00 786089000.00 -17760000.00 768329000.00 0.00 0.00 129005000.00 10 61.27 61.27 0.00 0.00 61.27 61.27 Manufacturing expenses 338800000.00 Other Expenses 259829000.00 Manufacturing expenses 1001357000.00 Other Expenses 803536000.00 -16778000.00 -17760000.00 0.00 0.00 0.00 0.00